C12N 2770/28151
Methods of production or purification of viral material
C12N2770/28151 (Methods of production or purification of viral material) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 8
- Assignees
- 12
- Inventors
- 17
- Latest grant
- 29 Dec 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 2 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Hepatitis E virus ORF2 capsid polypeptides and uses thereof29 Dec 2020US 10,875,896 B2Centre Hospitalier Regional Universitaire De Lille
- Methods for purification of a virus produced in vitro and clearance assay for the virus2 Jul 2019US 10,336,988 B2Grifols, S.A.
- Method for generating high-titer hepatitis E virus stocks and titration assay for hepatitis E virus19 Feb 2019US 10,208,291 B2Grifols, S.A.
- Infectious hepatitis E virus genotype 3 recombinants26 Dec 2017US 9,850,468 B2Royal Cornwall Hospital Trust
- Infectious hepatitis E virus genotype 3 recombinants10 Nov 2015US 9,181,530 B2Royal Cornwall Hospital Trust
- Hepatitis e virus-like particles (vlps) derived from consensus sequences10 Sep 2026US 2026/0263379 A1Novo Capsid Technologies LLC
- Hepatitis e virus orf2 capsid polypeptides and uses thereof26 Oct 2023US 2023/0340030 A1Centre Hospitalier Regional Universitaire De Lille
- Hepatitis e virus orf2 capsid polypeptides and uses thereof17 Jun 2021US 2021/0179669 A1Centre Hospitalier Regional Universitaire De Lille
- Hepatitis e virus orf2 capsid polypeptides and uses thereof21 Nov 2019US 2019/0352342 A1Centre Hospitalier Regional Universitaire De Lille
- Methods for purification of a virus produced in vitro and clearance assay for the virus26 Jan 2017US 2017/0022480 A1Grifols, S.A.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.